Roche descendants lose majority voting control

The Swiss family that has controlled drug giant Roche Holding AG for decades said one family member has dropped out of the group's voting pool. As a result, the family pool has lost majority voting control of the company. Report

Suggested Articles

Bristol-Myers already has one Opdivo combo approved in kidney cancer, but it’s going for another—and new trial data could be just the ticket.

Trodelvy's bladder cancer data look weaker compared with what Seattle Genetics' rival drug Padcev achieved in its own trial.

Merck’s Keytruda is battling Bristol Myers' Opdivo in adjuvant melanoma, and it just racked up trial results that will help it even the playing field.